|
Volumn 10, Issue , 2010, Pages 1967-1970
|
Pancreatic cancer: Molecular, biochemical, chemopreventive, and therapeutic aspects
|
Author keywords
Antibodies; Drug resistance; Epithelial; Metastasis; Pancreatic cancer; Proteins; Ubiquitination
|
Indexed keywords
3 INDOLEMETHANOL;
ANTISENSE OLIGONUCLEOTIDE;
BEVACIZUMAB;
CATECHIN;
CETUXIMAB;
CURCUMIN;
ERLOTINIB;
FLUOROURACIL;
GEMCITABINE;
GENISTEIN;
LYCOPENE;
RESVERATROL;
SMALL INTERFERING RNA;
TRASTUZUMAB;
ANTINEOPLASTIC AGENT;
MICRORNA;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GENE THERAPY;
CANCER PREVENTION;
CANCER RADIOTHERAPY;
CANCER RESISTANCE;
CANCER RISK;
CANCER SURVIVAL;
CHEMOPROPHYLAXIS;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG MECHANISM;
GENE DELIVERY SYSTEM;
HUMAN;
INTENSITY MODULATED RADIATION THERAPY;
NONHUMAN;
PANCREAS CANCER;
SHORT SURVEY;
DRUG THERAPY;
EDITORIAL;
EPITHELIUM CELL;
GENETIC PREDISPOSITION;
GENETICS;
MESODERM;
METABOLISM;
METHODOLOGY;
MULTIMODALITY CANCER THERAPY;
MUTATION;
PANCREAS TUMOR;
PATHOLOGY;
RADIOTHERAPY;
ANTINEOPLASTIC AGENTS;
COMBINED MODALITY THERAPY;
DRUG THERAPY;
EPITHELIAL CELLS;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
MESODERM;
MICRORNAS;
MUTATION;
PANCREATIC NEOPLASMS;
RADIOTHERAPY;
|
EID: 78349279570
PISSN: None
EISSN: 1537744X
Source Type: Journal
DOI: 10.1100/tsw.2010.184 Document Type: Short Survey |
Times cited : (4)
|
References (5)
|